A carregar...
Chemotherapy Combinations With Monoclonal Antibodies in Non-Hodgkin’s Lymphoma
Although the use of monoclonal antibodies as single agents has had a tremendous impact on the care of patients with non-Hodgkin’s lymphoma (NHL), the greatest benefit has been generated by the addition of monoclonal antibodies to conventional cytotoxic chemotherapy. Rituximab is the monoclonal antib...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2919066/ https://ncbi.nlm.nih.gov/pubmed/18381103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2008.02.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|